A study released this week has found that a majority of American adults are eligible to take semaglutide, the active ingredient in the medications Wegovy and Ozempic. Scientists at Harvard and ...

One very successful drug for type 2 diabetes management is semaglutide. It works as a glucagon-like peptide 1 (GLP-1) agonist, stimulating insulin release and reducing glucagon secretion ...